Clinical Trials Logo

Tinnitus, Subjective clinical trials

View clinical trials related to Tinnitus, Subjective.

Filter by:

NCT ID: NCT04623957 Not yet recruiting - Clinical trials for Tinnitus, Subjective

Safety and Efficacy of Acupressure Applied Through ForgTin© in Patients With Tinnitus

Start date: November 30, 2020
Phase: N/A
Study type: Interventional

The main objective of this clinical trial is to evaluate the effectiveness and safety of the medical product ForgTin with regard to the impairment and change in the sensation of tinnitus (volume, frequency, psychological stress).

NCT ID: NCT04565132 Completed - Clinical trials for Tinnitus, Subjective

HD-tDCS as a Treatment for Chronic Tinnitus

Start date: October 21, 2016
Phase: N/A
Study type: Interventional

Transcranial Direct Current Stimulation (tDCS) aims to induce cortical plasticity by modulating the activity of brain structures. The broad stimulation pattern, which is one of the main limitations of tDCS, can be overcome with the recently developed technique called High-Definition tDCS (HD-TDCS). The objective of the current study is to investigate the effect of HD-tDCS on tinnitus in a large patient cohort.

NCT ID: NCT04551404 Recruiting - Tinnitus Clinical Trials

Transcranial Electrical and Acoustic Stimulation for Tinnitus

tEAS
Start date: February 1, 2021
Phase: N/A
Study type: Interventional

Transcranial electrical stimulation (tES) is an umbrella term for non-invasive brain stimulation using weak currents. It comprises transcranial direct current stimulation (tDCS), which is the most established and used method applying constant direct current, transcranial alternating current stimulation (tACS) with sinusoidal current in a fixed frequency, and finally transcranial random noise stimulation (tRNS), which is a subform of tACS generating a random range of low and high frequency alternating currents. A pilot study conducted by Shekhawat and colleagues in 2015 tested the effects of simultaneous electrical and acoustic stimulation. Using tDCS and bilateral broadband noise simultaneously, they found that more tinnitus patients report an improvement in tinnitus perception in comparison to conditions only using tDCS or sham. Further similar approaches very published in recent years, namely a pilot study conducted by Teissmann et al in 2014; study protocols of Rabau et al. in 2015 and Shekhawat et al. in 2015; and an experimental study by Lee et al. in 2017. Results were indicative of a superior efficacy of combined electrical and acoustic approaches, while large-scale controlled studies have not been performed. The need for extension and replication of these approaches is therefore timely. The aim behind our proposed approach, similar to the bimodal approaches above, is to couple the effects of tRNS and acoustic stimulation (AS) for better temporary tinnitus suppression and possible reversal of maladaptive neuroplasticity related to tinnitus. We aim at targeting the (bilateral) auditory cortex with tRNS as in former studies and combine it with white noise (WN) stimulation. This specific combination is novel in its nature and is building on cortical excitability following tRNS.

NCT ID: NCT04449237 Not yet recruiting - Clinical trials for Tinnitus, Subjective

Mechanism Research of Tinnitus Based on Electroencephalogram and Acoustic Therapy Intervention

EEG-RCT
Start date: July 1, 2020
Phase: N/A
Study type: Interventional

This project aims to systematically and deeply study the central mechanism of tinnitus using electroencephalogram, and further study the treatment mechanism of tinnitus in combination with sound treatment strategies, so as to provide a research basis for clinical treatment of tinnitus.

NCT ID: NCT04404439 Recruiting - Tinnitus Clinical Trials

Treatment of Tinnitus With Migraine Medications

Start date: September 26, 2019
Phase: Phase 4
Study type: Interventional

Tinnitus represents one of the most common and distressing otologic problems, and it causes various somatic and psychological disorders that interfere with the quality of life. It is well-understood that many factors, such as poor education, lower income, or occupational, and recreational activity associated with high noise exposure, influences the prevalence and risk of tinnitus. Although the economic and emotional impact of tinnitus is large, there is currently no FDA-approved medication to treat this condition. However, there are pharmacological options to address the stress, anxiety, and depression that are caused by tinnitus. In this project, we intend to use medications for patients with tinnitus in order to decrease the impact of tinnitus on their daily life and activities.

NCT ID: NCT04382807 Enrolling by invitation - Clinical trials for Tinnitus, Subjective

Internet-delivered Group Counseling for Chronic Tinnitus

Start date: May 12, 2020
Phase:
Study type: Observational

In the treatment of chronic tinnitus, psycho-education plays an import role to provide more insights into the symptoms of tinnitus. However, the need for e-health is increasing. As such, it is important to investigate if these psycho-education sessions can be delivered online, with the same efficacy compared to the traditional face-to-face delivery.

NCT ID: NCT04310605 Completed - Clinical trials for Tinnitus, Subjective

Effectiveness of Specialised Cognitive Behavioural Therapy (CBT) for Tinnitus.

Start date: January 1, 2014
Phase:
Study type: Observational

This is an observational study of specialised CBT for tinnitus for adults delivered in routine care.

NCT ID: NCT04281953 Completed - Cancer Clinical Trials

Impact on Quality of Life of Long-term Ototoxicity in Cancer Survivors

Start date: September 5, 2019
Phase:
Study type: Observational

This project aims to explore, in depth, the burden of hearing loss and tinnitus on cancer survivors. Using semi-structured interviews, audiograms and a variety of validated questionnaires, the specific impact ototoxicity has on quality of life will be investigated. From this, we can identify the specific needs of patients experiencing hearing loss and tinnitus following chemotherapy and develop a tailored and personalised support system.

NCT ID: NCT04270916 Suspended - Cancer Clinical Trials

Prevalence and Impact on QoL From Ototoxicity in Cancer Survivors

Start date: February 3, 2020
Phase:
Study type: Observational

This study will involve collaborating with oncologists in the post-chemotherapy follow-up appointments. The participants who wish to consent to this study will then answer 3 short questionnaires (THI, HHIA and SF-36) about hearing loss, tinnitus and quality of life. The audiologist or the researcher, under the supervision of an audiologist, will then perform a simple, non-invasive hearing test on the participant. Should the participant have a hearing loss, they will be advise to seek help from their General Practitioner.

NCT ID: NCT04162405 Recruiting - Hearing Loss Clinical Trials

Tinnitus in Patients With and Without Sensorineural Hearing Loss

Start date: November 1, 2019
Phase:
Study type: Observational

The aim of this study is to evaluate hearing characteristics in patients with and without tinnitus using DPOAE and specific tinnitus severity index (TSI) and tinnitus handicap inventory (THI) questionnaires in both groups. Purpose of the research: Demonstrate that the characteristics of tinnitus depend on the presence and magnitude of hearing loss. Research participants: 150 patients coming for further audiological treatment due to tinnitus. Data will be collected from an electronic database that is filled in during diagnostic processing. During the diagnostic processing, TSI and THI questionnaires will be filled in, a tone audiogram (TA) and DPOAE will be performed.